Patents by Inventor Ryan K. Spencer

Ryan K. Spencer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11319348
    Abstract: Synthetic A? peptides, oligomers, their methods of synthesis, and their applications are provided. The A? peptides can form stable, soluble oligomers important for the advancement of knowledge, detection, and treatment of Alzheimer's disease. Antibodies specific to oligomeric A? and their methods of synthesis are also described.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: May 3, 2022
    Assignee: The Regents of the University of California
    Inventors: James S. Nowick, Adam G. Kreutzer, Ryan K. Spencer, Patrick J. Salveson
  • Publication number: 20200347099
    Abstract: Synthetic A? peptides, oligomers, their methods of synthesis, and their applications are provided. The A? peptides can form stable, soluble oligomers important for the advancement of knowledge, detection, and treatment of Alzheimer's disease. Antibodies specific to oligomeric A? and their methods of synthesis are also described.
    Type: Application
    Filed: April 13, 2020
    Publication date: November 5, 2020
    Applicant: The Regents of the University of California
    Inventors: James S. Nowick, Adam G. Kreutzer, Ryan K. Spencer, Patrick J. Salveson
  • Patent number: 10662226
    Abstract: Synthetic A? peptides, oligomers, their methods of synthesis, and their applications are provided. The A? peptides can form stable, soluble oligomers important for the advancement of knowledge, detection, and treatment of Alzheimer's disease. Antibodies specific to oligomeric A? and their methods of synthesis are also described.
    Type: Grant
    Filed: October 26, 2017
    Date of Patent: May 26, 2020
    Assignee: The Regents of the University of Caiifomia
    Inventors: James S. Nowick, Adam G. Kreutzer, Ryan K. Spencer, Patrick J. Salveson
  • Publication number: 20180118790
    Abstract: Synthetic A? peptides, oligomers, their methods of synthesis, and their applications are provided. The A? peptides can form stable, soluble oligomers important for the advancement of knowledge, detection, and treatment of Alzheimer's disease. Antibodies specific to oligomeric A? and their methods of synthesis are also described.
    Type: Application
    Filed: October 26, 2017
    Publication date: May 3, 2018
    Applicant: The Regents of the University of California
    Inventors: James S. Nowick, Adam G. Kreutzer, Ryan K. Spencer, Patrick J. Salveson